To the Editor There have been concerns regarding breast implants for a long time. On one hand, unfounded claims about autoimmune and connective tissue disease led to unnecessary fear and large-scale litigation.1,2 On the other hand, an increased risk of anaplastic large cell lymphoma is now recognized.3 These contrasting results emphasize the need for close and careful scrutiny.